TP53 c.809_810delinsGG ;(p.F270W)

Variant ID: 17-7577128-AA-CC

NM_000546.5(TP53):c.809_810delinsGG;(p.F270W)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Clinical and Immunological Effects of p53-Targeting Vaccines.

Frontiers In Cell And Developmental Biology
Zhou, Shan S; Fan, Chunmei C; Zeng, Zhaoyang Z; Young, Ken H KH; Li, Yong Y
Publication Date: 2021

Variant appearance in text: p53: F270W
PubMed Link: 34805170
Variant Present in the following documents:
  • Main text
  • fcell-09-762796.pdf
View BVdb publication page



Phase I dendritic cell p53 peptide vaccine for head and neck cancer.

Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Schuler, Patrick J PJ; Harasymczuk, Malgorzata M; Visus, Carmen C; Deleo, Albert A; Trivedi, Sumita S; Lei, Yu Y; Argiris, Athanassios A; Gooding, William W; Butterfield, Lisa H LH; Whiteside, Theresa L TL; Ferris, Robert L RL
Publication Date: 2014-05-01

Variant appearance in text: p53: F270W
PubMed Link: 24583792
Variant Present in the following documents:
  • Main text
View BVdb publication page



Development of multi-epitope vaccines targeting wild-type sequence p53 peptides.

Expert Review Of Vaccines
DeLeo, Albert B AB; Whiteside, Theresa L TL
Publication Date: 2008-09

Variant appearance in text: p53: F270W
PubMed Link: 18767952
Variant Present in the following documents:
  • Main text
View BVdb publication page